Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests

American Journal of Epidemiology

Volumn 141, Issue 2, 1995, Pages 166-172

  Brookmeyer, Ron ^a   Quinn, Thomas C ^b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Acquired immunodeficlency syndrome; Cross sectional studies; Epidemiologic methods; HIV seroprevalence statistics

Indexed keywords

ANTIGEN P24; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; INCIDENCE; POLYMERASE CHAIN REACTION; SEROLOGY;

CROSS-SECTIONAL STUDIES; EPIDEMIOLOGIC METHODS; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV SEROPREVALENCE; HUMAN; INCIDENCE; WORLD HEALTH;

EID: 0028796229     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a117404     Document Type: Article

References (34)

1. Centers for Disease Control. Estimates of HTV prevalence and projected AIDS cases: summary of a workshop, October 31-November 1, 1989. MMWR 1990;39:110-19.
2. Brookmeyer R, Gail MH. Minimum size of the acquired immunodeficiency syndrome (AIDS) epidemic in the United States. Lancet 1986;2:1320-2.
3. Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United States. Science 1991;253:37-42.
4. Bacchetti P, Segal M, Jewell NP. Backcalculation of HIV infection rates. Stat Sci 1993;8:82-119.
5. May RM, Anderson RM. Transmission dynamics of human immunodeficiency virus (HIV). Nature 1987;326:137-42.
6. Anderson RM. The role of mathematical models in the study of HTV transmission and the epidemiology of AIDS. AIDS 1988;1:241-56.
7. Allain JP, Laurian Y, Paul DA, et al. Serological markers in early stages of human immunodeficiency virus infection in hemophiliacs. Lancet 1986;2:1233-6.
8. Haseltine WA. Silent HIV infections. N Engl J Med 1989; 320:1487-9.
9. Busch MP, Taylor PE, Lenes BA, et al. Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. N Engl J Med 1990;323:1308-12.
10. Alter HJ, Epstein JS, Swenson SG, et al. Prevalence of human immunodeficiency virus type 2 p24 antigen in US blood donors-an assessment of the efficacy of testing in donor screening. N Engl J Med 1990;323:1312-17.
11. Clark SJ, Saag MS, Decker WD, et al. High titers of cyto- pathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 1991;324:954-60.
12. Daar ES, Moudgil T, Meyer R, et al. Transient high levels of uremia in patients with primary human immodeficiency virus type 1 infection. N Engl J Med 1991;324:961-4.
13. Clark SJ, Kelen GD, Henrard DR, et al. Unsuspected primary human immunodeficiency virus type 1 infection in seronegative emergency department patients. J Infect Dis 1994; 170: 194-7.
14. Centers for Disease Control and Prevention. Interpretation and use of Western blot assays for serodiagnosis of human immu-nodeficiency virus type 1 infection. MMWR 1989;38(suppl 7):l-7.
15. Longini IM, Clark WS, Byers RH. Statistical analysis of the states of HIV infection using a Markov model. Stat Med 1989;8:831-43.
16. Brookmeyer R, Day NE. Two-stage models for the analysis of cancer screening data. Biometrics 1987;43:657-69.
17. Baker JL, Kelen GD, Silverton KT, et al. Unsuspected human immunodeficiency virus in critcally ill emergency patients. JAMA 1987;257:2609-11.
18. Kelen GD, Fritz S, Qaqish B, et al. Unrecognized human immunodeficiency virus infection in emergency department patients. N Engl J Med 1988;318:1645-50.
19. Kelen GD, Hexter DA, Kline R, et al. Dynamics of the HTV epidemic in an inner-city emergency department (ED): implications for ED-based target screening (Abstract PO- C29-3257). Presented at the Ninth International Conference on AIDS, Berlin, June 6-11, 1993.
20. Cooper DA, Gold J, Maclean P, et al. Acute AIDS retrovirus infection. Lancet 1985;1:537-40.
21. Kessler HA, Blaauw B, Spear J. Diagnosis of human immunodeficiency virus infection in seronegative homosexuals presenting with an acute viral syndrome. JAMA 1987;258: 1196-9.
22. Zaaijer HL, Exel-Oehlers PV, Kraaijeveldt T, et al. Early detection of antibodies to HIV-1 by third generation assays. Lancet 1992;340:770-2.
23. Bowen PA, Lobel SA, Caruana RJ. Transmission of human immunodeficiency virus by transplantation: clinical aspects and time course of viral antigenemia and antibody production. Ann Intern Med 1988;108:46-8.
24. Gallarda JL, Henrard DR, Liu D, et al. Early detection of antibody to HIV-1 using an antigen conjugate immunoassay correlates with the presence of immunoglobulin M antibody. J Clin Microbiol 1992;30:2379-84.
25. Horsburgh CR, Qu CY, Jason IM. Duration of human immunodeficiency virus infection before detection of antibody. Lancet 1989;2:637-40.
26. Jackson JB, Sannerud K, Rhame FS, et al. Evaluation of two commercial tests for human immunodeficiency virus antigens in culture supernatant fluid. Am J Clin Pathol 1988;89: 788-90.
27. Harry DJ, Jennings MB, Yee J, et al. Antigen detection for human immunodeficiency virus. Clin Microbiol Rev 1989;2: 241-9.
28. Stramer SL, Heller JS, Coombs RW, et al. Markers of HIV infection prior to IgG antibody seropositivity. JAMA 1989; 262:64-9.
29. Busch MP, Eble B, Khayam-Bashi H, et al. Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. N Engl J Med 1991;325:1-5.
30. Henrad D, Mehaffey W, Allain JP. A sensitive viral capture assay for detection of plasma viremia in HTV infection individuals. AIDS Res Hum Retroviruses 1992;8:47-52.
31. Kline RL, Brothers TA, Brookmeyer R, et al. Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera. Clin Microbiol 1989;27:1449-52.
32. Satten GA, Longini IM. Estimation of incidence of HTV infection using cross-sectional marker surveys. Biometrics 1994;50:675-88.
33. Haenszel W, Loveland D, Sirken MG. Lung cancer mortality as related to residence and smoking histones. J Natl Cancer Inst 1962;28:947-1001.
34. Freeman J, Hutchison GB. Prevalence, incidence and duration. Am J Epidemiol 1980;112:707-23.